QMSAdvisor

Who We Serve: Clinical Area

Orthopedic Devices

Orthopedic companies tend to have deep catalogs: many sizes, many components and instrument sets that travel between hospitals. Each size and each set has its own records, and auditors know the long tail is where gaps hide. We help orthopedic manufacturers find them systematically.

Typical Regulatory Exposure

Orthopedic implants such as plates, screws, spinal systems and joint components are often cleared through 510(k), with some higher-risk designs on the PMA pathway. Machining, surface treatments, coatings and additive manufacturing are processes whose output cannot be fully verified by inspection, so process validation carries much of the quality evidence.

Reusable instruments shift part of the quality burden to the hospital. The manufacturer has to provide validated reprocessing instructions, and those instructions need to work for the real instrument geometry and the cleaning and sterilization methods hospitals actually use. Loaner sets that circulate between facilities add questions about inspection, refurbishment and traceability between uses.

Catalog size multiplies everything. A family of implants with many sizes needs a defensible worst-case rationale for testing, labeling that is correct for every variant, and UDI data that matches what is actually in the box. Under the EU MDR, orthopedic implants also face clinical evidence and post-market surveillance expectations that are hard to meet with legacy data alone.

Where Audits Find Gaps

  1. 01

    Worst-Case Size Rationale Missing

    Testing was done on selected sizes, but no documented rationale shows why those sizes represent the worst case for strength, fatigue or cleaning.

  2. 02

    Reprocessing Instructions Not Validated as Written

    The cleaning and sterilization instructions in the IFU do not match the parameters used in the validation, or the validation used a simpler instrument than the one in the set.

  3. 03

    Loaner Set Returns Uninspected

    Instrument sets come back from hospitals and go out again without a documented inspection, functional check or record of what was replaced.

  4. 04

    Machining Residues Not Characterized

    Cutting fluids and polishing compounds are removed by a cleaning process that was validated before a coolant, detergent or supplier changed.

  5. 05

    Label and UDI Errors Across Variants

    With many SKUs, labels and UDI records for a few variants carry the wrong size or lot format, and the label review process only samples.

  6. 06

    Additive Process Changes Without Revalidation

    Powder lots, build parameters or post-processing steps for printed components changed without an assessment of their effect on the validated process.

Relevant Standards and Regulations

Relevant Services

Audits and Inspections You May Face

Questions

Who is responsible for instrument reprocessing, us or the hospital?

The hospital performs it, but the manufacturer is responsible for instructions that are validated and achievable in a typical hospital setting. If complaints show hospitals cannot follow your instructions, treat that as a signal to review them.

How should loaner instrument sets fit into the QMS?

Treat each return as a controlled event: inspection, cleaning, functional checks, replacement of worn or missing items, and a record that ties the set to its next use. Many firms manage loaners outside the QMS, which is exactly where auditors find the gap.

Can you review a large catalog efficiently?

That is where the AI-assisted first pass helps most. It compares labels, UDI records, test rationales and IFUs across variants and flags inconsistencies, and an advisor reviews each one before it becomes a finding.

Orthopedic Devices

Get an Advisor's View of Your Quality System

Tell us about your devices and the audit or inspection ahead, and an advisor will scope an assessment for your kind of product. Please don't send confidential documents yet: secure upload is set up after onboarding.